Abstract
Key PointsTXA is an active-site inhibitor of uPA. TXA attenuates MDA-MB-231 BAG cell migration and inhibits endogenous uPA activity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1182/bloodadvances.2018025429
Copy DOIJournal: Blood advances | Publication Date: Mar 12, 2019 |
Citations: 22 |
Key PointsTXA is an active-site inhibitor of uPA. TXA attenuates MDA-MB-231 BAG cell migration and inhibits endogenous uPA activity.
Join us for a 30 min session where you can share your feedback and ask us any queries you have